1
|
Joly F, Quilliot D, Beau P, Seguy D, Chambrier C, Poullenot F, Armengol-Debeir L, Nuzzo A, Lallemand J, Layec S, Thibault R, Boehm V, Schneider S. Effet du teduglutide (agoniste du GLP2) à 6 mois dans la cohorte française de patients adultes avec syndrome de grêle court (SGC). NUTR CLIN METAB 2018. [DOI: 10.1016/j.nupar.2018.09.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
2
|
Joly F, Quilliot D, Beau P, Poullenot F, Armengol-Debeir L, Chambrier C, Lallemand J, Boehm V, Nuzzo A, Corcos O, Schneider S. OR11: First Study in ‘Real Life’ on the Effect of Teduglutide at 3 Months in Acohort of Adult Patients with Short Bowel Syndrome (SBS). Clin Nutr 2017. [DOI: 10.1016/s0261-5614(17)30776-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Joly F, Quilliot D, Beau P, Poullenot F, Armengol-Debeir L, Chambrier C, Lallemand J, Nuzzo A, Boehm V, Bataille J, Schneider S. Première étude en “vie réelle” sur l’effet du téduglutide (agoniste du GLP2) à 3 mois dans une cohorte nationale de patients adultes avec syndrome de grêle court. NUTR CLIN METAB 2017. [DOI: 10.1016/j.nupar.2017.06.069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
4
|
Bequet E, Sarter H, Fumery M, Vasseur F, Armengol-Debeir L, Pariente B, Ley D, Spyckerelle C, Coevoet H, Laberenne JE, Peyrin-Biroulet L, Savoye G, Turck D, Gower-Rousseau C. Incidence and Phenotype at Diagnosis of Very-early-onset Compared with Later-onset Paediatric Inflammatory Bowel Disease: A Population-based Study [1988-2011]. J Crohns Colitis 2017; 11:519-526. [PMID: 28453757 DOI: 10.1093/ecco-jcc/jjw194] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2016] [Accepted: 10/26/2016] [Indexed: 12/19/2022]
Abstract
BACKGROUND AND AIMS Very-early-onset inflammatory bowel disease [VEO-IBD] is a form of IBD that is distinct from that of children with an older onset. We compared changes over time in the incidence and phenotype at diagnosis between two groups according to age at IBD diagnosis: VEO-IBD diagnosed before the age of 6 years, and early-onset IBD [EO-IBD] diagnosed between 6 and 16 years of age. METHODS Data were obtained from a cohort enrolled in a prospective French population-based registry from 1988 to 2011. RESULTS Among the 1412 paediatric cases [< 17 years], 42 [3%] were VEO-IBD. In the VEO-IBD group, the incidence remained stable over the study period. In contrast, the incidence of EO-IBD increased from 4.4/105 in 1988-1990 to 9.5/105 in 2009-2011 [+116%; p < 10-4]. Crohn's disease [CD] was the most common IBD, regardless of age, but ulcerative colitis [UC] and unclassified IBD were more common in VEO-IBD cases [40% vs 26%; p = 0.04]. VEO-IBD diagnosis was most often performed in hospital [69% vs 43%; p < 10-3]. Rectal bleeding and mucous stools were more common in patients with VEO-IBD, whereas weight loss and abdominal pain were more frequent in those with EO-IBD. Regarding CD, isolated colonic disease was more common in the VEO-IBD group [39% vs 14%; p = 0.003]. CONCLUSIONS In this large population-based cohort, the incidence of VEO-IBD was low and stable from 1988 to 2011, with a specific clinical presentation. These results suggest a probable genetic origin for VEO-IBD, whereas the increase in EO-IBD might be linked to environmental factors.
Collapse
Affiliation(s)
- E Bequet
- Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University Jeanne de Flandre Children's Hospital, University of Lille, Lille, France
| | - H Sarter
- Public Health, Epidemiology and Economic Health, Registre EPIMAD, Maison Régionale de la Recherche Clinique, Lille University and Hospital, Lille, France
- Lille Inflammation Research International Center LIRIC - UMR 995 Inserm Lille 2 University, CHRU de Lille, Lille, France
| | - M Fumery
- Gastroenterology Unit, EPIMAD Registry, CHU Amiens Sud, Amiens University Hospital, Amiens, France
| | - F Vasseur
- Biostatistics Unit, EA 2694, Lille University and Hospital, Lille, France
| | - L Armengol-Debeir
- Gastroenterology Unit, EPIMAD Registry, Hôpital Charles Nicolle, Rouen University Hospital, Rouen, France
| | - B Pariente
- Gastroenterology Unit, Hôpital Huriez, Lille University Hospital, Lille, France
| | - D Ley
- Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University Jeanne de Flandre Children's Hospital, University of Lille, Lille, France
- Lille Inflammation Research International Center LIRIC - UMR 995 Inserm Lille 2 University, CHRU de Lille, Lille, France
| | - C Spyckerelle
- Paediatric Unit, St Vincent Hospital, Catholic University, Lille, France
| | - H Coevoet
- Gastroenterology Unit, Les Bonnettes Private Hospital, Arras, France
| | - J E Laberenne
- Gastroenterology Unit, General Hospital, Seclin, France
| | - L Peyrin-Biroulet
- Gastroenterology Unit, Inserm U954, Université de Lorraine, Nancy, France
| | - G Savoye
- Gastroenterology Unit, EPIMAD Registry, Hôpital Charles Nicolle, Rouen University Hospital, Rouen, France
| | - D Turck
- Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Lille University Jeanne de Flandre Children's Hospital, University of Lille, Lille, France
- Lille Inflammation Research International Center LIRIC - UMR 995 Inserm Lille 2 University, CHRU de Lille, Lille, France
| | - C Gower-Rousseau
- Public Health, Epidemiology and Economic Health, Registre EPIMAD, Maison Régionale de la Recherche Clinique, Lille University and Hospital, Lille, France
- Lille Inflammation Research International Center LIRIC - UMR 995 Inserm Lille 2 University, CHRU de Lille, Lille, France
| |
Collapse
|
5
|
Ghione S, Michaud L, Sarter H, Armengol-Debeir L, Fumery M, Savoye G, Ley D, Spyckerelle C, Pariente B, Mouterde O, Djeddi D, Peyrin-Biroulet L, Gower C, Turck D. Augmentation de l’incidence de la maladie de Crohn et de la rectocolite hémorragique chez l’adolescent sur une période de 21ans. Arch Pediatr 2016. [DOI: 10.1016/j.arcped.2016.02.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
6
|
Di Fiore F, Armengol-Debeir L, Blanchard F, Chapusot C, Tournier B, Sesboué R, Sefrioui D, Basile P, Gangloff A, Hebbar M, Copin M, Vasseur C, Tuech J, Vermeulin T, Houivet E, Frebourg T, Sabourin J, Lepage C, Michel P. A Bar Code of Selected Gene Copy Number Alterations is Associated with Disease-Free Survival in Stage Ii-Iii Microsatellite Stable (Mss) Colon Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu333.67] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
7
|
Langlois V, Armengol G, Girszyn N, Lepileur L, Armengol-Debeir L, Benhamou Y, Lévesque H. [Multiple intra-abdominal nodules]. Rev Med Interne 2014; 35:840-2. [PMID: 24503384 DOI: 10.1016/j.revmed.2013.12.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/11/2013] [Accepted: 12/26/2013] [Indexed: 11/27/2022]
Affiliation(s)
- V Langlois
- Département de médecine interne, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - G Armengol
- Département de médecine interne, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France.
| | - N Girszyn
- Département de médecine interne, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - L Lepileur
- Département d'hépato-gastroentérologie, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - L Armengol-Debeir
- Département d'hépato-gastroentérologie, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - Y Benhamou
- Département de médecine interne, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| | - H Lévesque
- Département de médecine interne, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France
| |
Collapse
|
8
|
Cheddani H, Dauchet L, Charpentier C, Fumery M, Salleron J, Bouvier AM, Dupas JL, Vasseur F, Lerebours E, Armengol-Debeir L, Laberenne E, Peyrin-Biroulet L, Colombel JF, Savoye G, Gower-Rousseau C. DOP094 Cancer in elderly-onset inflammatory bowel disease: A population-based study. J Crohns Colitis 2014. [DOI: 10.1016/s1873-9946(14)60119-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/27/2023]
|
9
|
Lerebours E, Joly F, Chambrier C, Schneider S, Séguy D, Fontaine E, Armengol-Debeir L, Blot J, Roth H. O53 Étude de l’efficacité d’un verrou taurolidine dans la prévention secondaire des infections liées à la voie veineuse centrale en nutrition parentérale à domicile. Résultat d’une étude prospective randomisée multicentrique. NUTR CLIN METAB 2013. [DOI: 10.1016/s0985-0562(13)70325-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
10
|
Armengol-Debeir L, Killian A, Sesboué R, Lamy A, Tuech JJ, Sabourin JC, Frébourg T, Michel P, Di Fiore F. Impact pronostique de la détection simultanée d’altérations moléculaires quantitatives par QMPSF dans les cancers du côlon stade II et III. Ann Pathol 2011. [DOI: 10.1016/j.annpat.2011.09.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|